Why Is Helius Medical Tech Stock (HSDT) Up 100% Today?
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Dane Andreeff, President and CEO of Helius Medical Tech, said, 'We are actively pursuing broader in-network coverage for PoNS at list price from major commercial payers, while continuing to negotiate reimbursement on a case-by-case basis.' PoNS is an orally applied therapy that delivers neurostimulation via a non-implantable mouthpiece.
HSDT stock rocketed 98.82% during pre-market trading on Wednesday. That's a welcome change from its 91.50% drop year-to-date and 94.88% fall over the past 12 months.
Is Helius Medical Technologies Stock a Buy, Sell, or Hold?
Wall Street's coverage of Helius Medical Technologies is thin, but TipRanks' AI analyst Spark fills that gap. Spark rates HSDT stock an Underperform (38) with a $1 price target. The AI analyst cites 'significant financial and operational challenges' as reasons for this rating and price.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
IonQ price target raised to $55 from $50 at Benchmark
Benchmark analyst David Williams raised the firm's price target on IonQ (IONQ) to $55 from $50 and keeps a Buy rating on the shares after having recently hosted a fireside chat with CEO Niccolo de Masi and CFO Thomas Kramer. IonQ is positioning itself as 'a leader in both quantum computing and the increasingly critical field of quantum networking,' contends the analyst, who believes the company has the most commercial business model and differentiated go to market strategy among peers. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on IONQ: Disclaimer & DisclosureReport an Issue IonQ's Strategic Positioning and Growth Potential in Quantum Computing: A Buy Rating Analysis Analysts Say Buy IonQ Stock, but Is Any Upside Really Left? Black Diamond, Nike, Apple, Block, IonQ: Trending by Analysts Mixed options sentiment in IONQ with shares down 0.89% Quantum Computing Stocks QBTS and IONQ Rally as Cantor Assigns 'Buy' Rating Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
AST SpaceMobile price target raised to $51 from $42 at Roth Capital
Roth Capital raised the firm's price target on AST SpaceMobile (ASTS) to $51 from $42 and keeps a Buy rating on the shares. Positive news flow and an improving competitive lansdscape has driven the stock up 89% since the firm's initiation in April, the analyst tells investors in a research note. T-Mobile's (TMUS) announcement of 1.8M registrations for Starlink-enabled D2D text services is a key market validation given its inferior service and $10 pricing, and the firm is 'extremely positive' for AST SpaceMobile penetration and pricing, Roth added. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on ASTS: Disclaimer & DisclosureReport an Issue AST SpaceMobile Repurchases Convertible Notes to Reduce Dilution AST SpaceMobile secures additional $100M of liquidity from equipment financing AST SpaceMobile Announces New Class A Stock Issuance Mixed options sentiment in AST SpaceMobile with shares down 2.26% Vodafone, AST SpaceMobile announce SatCo to be headquartered in Luxembourg Sign in to access your portfolio
Business Insider
4 hours ago
- Business Insider
Citi Remains a Buy on Shell (UK) (SHEL)
In a report released today, Alastair Syme from Citi reiterated a Buy rating on Shell (UK). The company's shares closed yesterday at p2,553.00. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Syme is a 4-star analyst with an average return of 15.5% and a 62.22% success rate. Syme covers the Energy sector, focusing on stocks such as ENI S.p.A., BP p.l.c., and Conocophillips. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Shell (UK) with a p2,987.55 average price target, representing a 17.02% upside. In a report released yesterday, Jefferies also maintained a Buy rating on the stock with a £30.00 price target. Based on Shell (UK)'s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of p69.23 billion and a net profit of p4.78 billion. In comparison, last year the company earned a revenue of p72.48 billion and had a net profit of p7.36 billion
